Fully Booked | Wuxi Business Delegation: Exploring Synergies in Food Processing & Pharmaceuticals 无锡商务考察之旅：共探瑞士食品加工与英国制药产业协同新机遇

EN

China’s ongoing industrial upgrade is increasingly driven by the convergence of life sciences and advanced manufacturing. As consumer health awareness rises and regulatory standards tighten, the food processing and pharmaceutical sectors are rapidly adopting digitalization and smart technologies to enhance production efficiency, ensure product safety, and accelerate innovation. This structural shift is creating new synergies across the value chain, where precision engineering, automated processing, and biopharmaceutical R&D are reshaping traditional industry boundaries.

In this context, BritCham Shanghai and SwissCham China – Shanghai, co-organised with the Wuxi Council for the Promotion of International Trade (Wuxi CCPIT), will bring international enterprises to Wuxi on September 3, 2026, for an exclusive fact-finding trip to explore collaborative opportunities within this evolving ecosystem.

Participants will visit  Pfizer pharmaceutical（Wuxi）and Bühler Group to witness firsthand how digitalisation is transforming the pharmaceutical and food processing sectors. The program includes a factory tour at Bühler Group showcasing advanced manufacturing processes for food processing equipment, alongside a technical exchange on digital solutions applied in the food industry. These visits will highlight state-of-the-art production, R&D capabilities, and smart manufacturing practices, offering practical insights into cross-sector innovation and value chain integration.

*Please note that the event will be conducted bilingually.

中文

中国正在推进的产业升级，越来越多地受到生命科学与先进制造深度融合的推动。随着消费者健康意识的提升和监管标准的日益严格，食品加工与医药行业正加速采用数字化与智能技术，以提升生产效率、保障产品安全并加快创新步伐。这一结构性转变正在价值链各环节催生新的协同效应，精密工程、自动化加工与生物医药研发正不断重塑传统行业的边界。

在此背景下，上海英国商会与中国瑞士商会上海分会将携手无锡市贸促会（Wuxi CCPIT），于2026年9月3日组织国际企业赴无锡开展专属考察活动，探索在这一不断演进的产业生态中的合作机遇。

参与者将实地走访辉瑞制药（无锡）（ Pfizer pharmaceutical（Wuxi））与布勒集团（Bühler Group），直观了解数字化如何推动医药与食品加工行业的变革。活动行程包括参观布勒集团工厂，了解食品加工设备的先进制造工艺，并围绕食品行业的数字化解决方案开展技术交流。这些考察将集中展示前沿的生产与研发能力以及智能制造实践，为跨行业创新与价值链整合提供切实的洞察。

*请注意：本次活动将采用双语进行。

• 9:00 – 9:20 am | Arrival at Wuxi Railway Station & Registration
• 9:20 – 10:20 am | Transportation to Pfizer (Wuxi)
• 10:20 – 11:10 am | Company Visit at Pfizer (Wuxi)
• 11:10 am – 12:00 pm | Transportation to Luncheon Venue
• 12:00 – 2:00 pm | Business Luncheon & Networking
• 2:00 – 2:30 pm | Transportation to Buhler Group
• 2:30 – 4:30 pm | Company Visit at Buhler Group
• 4:30 – 5:30 pm | Transportation back to Shanghai

*BritCham Shanghai reserves the right to alter the above agenda at any time. 

Transportation 交通:

Transportation between Shanghai and Wuxi shall be arranged by the guest. Shuttle bus transportation in town is provided by the development zone.

来往于上海和无锡的交通需由客人自行安排。市内班车由开发区提供。

【Updated】Meeting Point 集合地点:

Platform of Wuxi Railway Station (More details of the meeting point would be announced prior to the event.)

无锡站集合（更多集合点信息将于活动前公布）

【Updated】Meeting Time 集合时间:

9 – 9:20 am

Suggested High-Speed Train Timetable 高铁时刻建议

Outbound:

【Updated】D952 08:30 – 09:09 From Shanghai Railway Station (上海火车站) to Wuxi Railway Station (无锡火车站)

Return:

G737 16:51 – 17:27 From Wuxi East  (无锡东站) to Shanghai Hongqiao (上海虹桥站)

*For reference only. The official rail schedule on the day of the event shall prevail.

*仅供参考，具体高铁时刻以活动当天官方时刻为准。

RSVP deadline: Tuesday, September 1, 2026

报名截止日期：2026年9月1日（周二）

Notes:

Since there are limited seats available in the delegation, BritCham Shanghai will reserve the right to prioritise the participations from our member sector relevant companies. The final confirmation will be communicated by email to all applicants.

Submitting the registration form does not guarantee a confirmed place. Successful applicants will receive an approval email with further details.

提交报名表并不代表席位已获确认。报名成功者将收到审批通过邮件及后续详情。

因本次活动席位有限，上海英国商会将优先筛选来自会员行业相关企业的报名，请以最终邮件确认为准。

Cancellation Policy 取消政策：

In case of cancellation, please kindly note you must email the BritCham Shanghai Event staff eloise.zhang@britishchambershanghai.cn before 5 pm, 1 Sep. Due to the service charges of Glueup and online payment platforms, we can only partially refund up to 90% of your ticket price and payment will be processed within 14 days after the event via your original payment method. However, it is non-refundable for a cancellation request made beyond the above-mentioned timeframe.

Bühler Group 布勒集团 

Company Profile:

Billions of people come into contact with Bühler technologies to cover their basic needs for food and mobility every day. Bühler develops the best process solutions along complete value chains. Bühler has two business pillars: Grains & Food solutions ensure safe and healthy food and feed. Advanced Materials contributes to the production of energy-efficient vehicles and buildings. As a Swiss company with a history of more than 160 years, Bühler is active in 140 countries around the world and operates a global network of 105 service stations, 27 manufacturing sites, and Application Centers in 26 locations globally. Bühler invests up to 5% of turnover into research and development. In 2023, 12,000 employees generated a turnover of CHF 2.8 billion.

公司简介：

每天，数以亿计的人们都在享用布勒技术，满足自己在食品和交通出行领域的日常所需。布勒致力于在整个价值链中开发卓越的工艺解决方案，拥有两大业务支柱：谷物食品解决方案，确保安全和健康的食品与饲料；先进材料解决方案，致力于生产节能车辆和建造节能建筑。作为一家拥有160多年历史的瑞士企业，布勒活跃于全球140个国家，拥有包含27个生产基地和105家客户服务中心的全球网络，同时在全球26个地区拥有应用与培训中心。每年布勒将营业额的5%用于研发。2025年，来自于布勒全球的12,000 多名员工创造了28亿瑞士法郎的销售额。

Pfizer pharmaceutical（Wuxi）辉瑞制药（无锡）

Company Profile:

Pfizer pharmaceutical （Wuxi）company limited was established in September 1995.  As a key member of Pfizer’s global manufacturing network, Pfizer Wuxi is committed to its long-term promise of “In China, For China.” Leveraging world-class technologies, quality standards and operational excellence, the site continues to create value for patients and contribute to China’s biopharmaceutical industry

Wuxi Plant adheres to the concept of‘Science Will Win’ and its main products are Pharmorubicin, Zavedos, Cytosar and Zithromax.

To better meet the growing healthcare needs of patients in China, the Wuxi Plant has continuously strengthened its manufacturing capabilities. Based on the needs of the Chinese market, the Freeze Dryer and Filling Line with advanced isolator technology was officially launched. The project incorporates world-class isolator technology and fully automated manufacturing processes, enabling end-to-end aseptic control throughout production. This significantly enhances product quality, reliability, and patient safety while supporting the sustainable development of China’s healthcare industry.

Inspired by Pfizer’s purpose of delivering breakthroughs that change patients’ lives, Pfizer Wuxi upholds the highest standards of quality, safety and value. Through advanced manufacturing technologies, robust quality systems and digital innovation, the site supports the Healthy China initiative, improves access to medicines, and benefits more patients.

公司简介：

辉瑞制药（无锡）有限公司成立于1995年9月，是辉瑞公司投资设立的独资企业，是一家以科学为基础的，以患者为先的生产基地。作为辉瑞全球生产网络的重要组成部分，辉瑞无锡始终坚持“扎根中国、服务中国”，致力于将全球先进的生产技术、质量标准和管理经验与中国市场需求相结合，持续为患者健康创造价值，为生物医药产业高质量发展贡献力量。

辉瑞无锡主要生产法玛新、善唯达、赛德萨和希舒美产品。

辉瑞无锡积极推进中国健康事业，基于市场需求，引进了当前最现代的无菌冻干生产线。该生产线采用目前先进的隔离器技术，全自动化生产，实现无菌制剂生产全过程的无菌控制,最大程度地保证产品质量。

秉承“为患者带来改变其生活的突破创新”使命，辉瑞无锡始终奉行严格的质量、安全和价值标准，持续推动先进生产技术、质量管理体系及数字化实践在本土落地，积极推动“健康中国”建设，提高产品可及性，惠及更多患者。